Category Archives: Hypogonadism Management

Reading Time: 2 minutesIntroduction to Hypogonadism Hypogonadism, a condition characterized by the body's inability to produce sufficient testosterone, is a prevalent health concern among American males. This hormonal deficiency can manifest in various symptoms, including decreased libido, fatigue, and mood disturbances. Understanding the implications of hypogonadism is crucial, not only for managing these symptoms but also for assessing its potential impact on other aspects of male health, such as prostate function. The Prostate and Its Functions The prostate gland, a small yet vital organ in the male reproductive system, plays a significant role in semen production and ejaculation. Its health is paramount, as … Read more »

Reading Time: 2 minutesIntroduction to Hypogonadism Hypogonadism, a condition characterized by the body's inability to produce sufficient testosterone, poses significant health challenges for affected American males. This hormonal deficiency can lead to a myriad of symptoms, including decreased libido, fatigue, and muscle weakness, profoundly impacting quality of life. As medical science advances, the ethical considerations surrounding the treatment of hypogonadism have become increasingly pertinent, necessitating a thorough examination of the moral landscape that governs patient care. Ethical Considerations in Diagnosis The diagnosis of hypogonadism must be approached with a high degree of ethical responsibility. Clinicians are tasked with ensuring that the diagnostic process … Read more »

Reading Time: 2 minutesIntroduction to Hypogonadism Hypogonadism, a condition characterized by the body's inability to produce sufficient testosterone, remains a significant yet under-discussed health issue among American males. This hormonal deficiency can lead to a myriad of symptoms including decreased libido, fatigue, and reduced muscle mass, which can profoundly impact quality of life. The necessity for comprehensive medical education on hypogonadism is paramount to ensure that physicians are equipped to diagnose and manage this condition effectively. The Prevalence and Impact of Hypogonadism Recent studies indicate that hypogonadism affects approximately 2-6% of men in the United States, with prevalence increasing with age. Despite its … Read more »

Reading Time: 2 minutesUnderstanding Hypogonadism Hypogonadism is a medical condition characterized by the body's inability to produce sufficient levels of testosterone, the primary male sex hormone. This deficiency can lead to a myriad of health issues, including decreased libido, erectile dysfunction, fatigue, and loss of muscle mass. While medical treatments such as testosterone replacement therapy are available, an often overlooked yet vital component in managing this condition is regular exercise. The Impact of Exercise on Testosterone Levels Engaging in regular physical activity has been shown to have a positive effect on testosterone levels. Resistance training, in particular, has been identified as an effective … Read more »

Reading Time: 2 minutesIntroduction to Hypogonadism and Autoimmune Disorders Hypogonadism, characterized by the body's inability to produce adequate levels of testosterone, poses significant health challenges for American males. This condition not only affects sexual health and fertility but also has broader implications for overall well-being. Intriguingly, recent medical research has begun to uncover a potential link between hypogonadism and autoimmune disorders, where the immune system mistakenly attacks the body's own tissues. Understanding this connection is crucial for effective management and treatment strategies tailored to American men. The Pathophysiology of Hypogonadism Hypogonadism can be classified into primary and secondary forms. Primary hypogonadism arises from … Read more »

Reading Time: < 1 minuteLow Testosterone (Hypogonadism) - Part 2 Low Testosterone in Men (Hypogonadism) with Dr. Richard Bebb - Part 2. Live video from our Public Forum on Men's Health which took place Nov. 18, 2009 at Vancouver General Hospital.From:aboutmenshealthViews:4908 0ratingsTime:07:14More inPeople Blogs Go here to see the original: Low Testosterone (Hypogonadism) - Part 2 - Video … Read more »

Reading Time: < 1 minuteHypogonadism Treatment and Symptoms XXXXXX◄ Hypogonadism treatment mdash; Finding the right information about Hypogonadism treatment symptoms, is crucial to managing Hypogonadism. Learn more about the best current treatment for you.► XXXXXXX Website: http://www.MainMD.com Provides valuable health information, tools for managing your health, and support to those who seek information. You can trust that our content is timely and credible. Discussions http://www.MainMD.com YouTube: http://www.YouTube.com Facebook: http://www.Facebook.com Twitter: http://www.Twitter.com THIS VIDEO CAN NOT BE RE-UPLOADED OR USED IN ANY WAY WITHOUT WRITTEN PERMISSION FROM MAINMD PRODS -MainMD All Rights Reserved- By: MainMDcom Read this article: Hypogonadism ¦ Treatment and Symptoms … Read more »

Reading Time: < 1 minuteMale hypogonadism Prof Ossama Fouda Male hypogonadism Prof Ossama Fouda. By: mansvu See original here: Male hypogonadism Prof Ossama Fouda - Video … Read more »

Reading Time: < 1 minuteHypogonadism - what should you do Dr. Richard Bebb is a Clinical Assistant Professor of Endocrinology and Metabolism at the University of British Columbia. By: aboutmenshealth Visit link: Hypogonadism - what should you do - Video … Read more »

Reading Time: < 1 minuteLow Testosterone (Hypogonadism) - Part 3 Low Testosterone in Men (Hypogonadism) with Dr. Richard Bebb - Part 3. Live video from our Public Forum on Men's Health which took place Nov. 18, 2009 at Van... By: aboutmenshealth More here: Low Testosterone (Hypogonadism) - Part 3 - Video … Read more »

Reading Time: 2 minutesGlendale, CA (PRWEB) December 15, 2013 Audio-Digest Foundation announces the release of Oncology Volume 04, Issue 16: Highlights from Future Directions: Palliative Medicine and Supportive Oncology. The goal of this program is to improve the palliative management of symptoms associated with cancer and its treatment. After hearing and assimilating this program, the clinician will be better able to: 1. Diagnose and treat hypogonadism in patients with cancer. 2. Recognize the role of hypogonadism in metabolic syndrome. 3. Select the most effective treatments available for patients with symptoms due to malignant bowel obstruction. 4. Anticipate specific adverse effects (AEs) associated with … Read more »

Reading Time: < 1 minuteNURS805 Hypogonadism Lecture NURS805. By: ctelt fhsu View original post here: NURS805 Hypogonadism Lecture - Video … Read more »

Reading Time: 2 minutesby Culley C. Carson III, MD Hypogonadism is defined as deficient or absent male gonadal function that results in insufficient testosterone secretion. Hypogonadism may be primary due to testicular failure, or secondary due to hypothalamic-pituitary axis dysfunction, resulting in the production or release of insufficient testosterone to maintain testosterone-dependent functions and systems. Hypogonadism can also result from a combination of testicular failure and hypothalamic-pituitary axis dysfunction. Hypogonadism affects an estimated 4 to 5 million men in the United States, and although it may occur in men at any age, low testosterone levels are especially common in older males. More than … Read more »

Reading Time: < 1 minuteOverview of Testosterone Deficiency Testosterone production declines naturally with age. Low testosterone, or testosterone deficiency (TD), may result from disease or damage to the hypothalamus, pituitary gland or testicles that inhibits hormone secretion and testosterone production, and is also known as hypogonadism. Depending on age, insufficient testosterone production can lead to abnormalities in muscle and bone development, underdeveloped genitalia and diminished virility. Testosterone is the androgenic hormone primarily responsible for normal growth and development of male sex and reproductive organs, including the penis, testicles, scrotum, prostate and seminal vesicles. It facilitates the development of secondary male sex characteristics such as … Read more »

Reading Time: < 1 minuteINTRODUCTION Hypogonadism in a male refers to a decrease in either or both of the two major functions of the testes: sperm production and/or testosterone production (see "Male reproductive physiology"). These abnormalities can result from disease of the testes (primary hypogonadism) or disease of the pituitary or hypothalamus (secondary hypogonadism). The distinction between these disorders is made by measurement of the serum concentrations of luteinizing hormone (LH) and follicle stimulating hormone (FSH): The patient has primary hypogonadism if his serum testosterone concentration and/or sperm count are low and/or his serum LH and FSH concentrations are high. The patient has secondary … Read more »

Reading Time: < 1 minuteThe effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density Read the article: http://onlinelibrary.wiley.com/doi/10.1111/bju.12870/abstract Ali A. Dabaja, Campbell F. B... By: BJUIjournal See the original post here: The effect of hypogonadism and testosterone-enhancing therapy - Video … Read more »

Reading Time: 3 minutesMALVERN, Pa. and NEW YORK, Nov. 7, 2012 /PRNewswire/ --Auxilium Pharmaceuticals, Inc. (AUXL), a specialty biopharmaceutical company, and Pfizer Inc. (PFE) are amending their collaboration agreement for the development, commercialization and supply of XIAPEX in the European Union (EU) and certain other European and Eurasian countries (the "Collaboration Agreement"). As a result of this amendment, the Collaboration Agreement will terminate no later than April 24, 2013. Prior to the mutual termination date, the parties will continue to perform all of their obligations as described in the Collaboration Agreement. After the termination date, rights to commercialize XIAPEX and responsibility for regulatory … Read more »

Reading Time: 3 minutesTHE WOODLANDS, Texas, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.(R) (RPRX) today announced financial results for the third quarter ended September 30, 2012. Liquidity and Capital Resources The Company had cash and cash equivalents of approximately $29.6 million as of September 30, 2012 as compared to $4.6 million as of December 31, 2011. On February 1, 2012, we completed a registered direct offering to certain institutional investors, including certain existing shareholders, of 2,463,537 shares of our common stock at a price per share of $4.50. Net proceeds to us, after deducting placement agent's fees and offering expenses, were … Read more »

Reading Time: 2 minutesMesothelioma Lawyers raising awareness of new drug that could help improve the health of mesothelioma patients. Dallas, TX (PRWEB) December 17, 2012 "This is another step forward in the medical battle against mesothelioma," said John Langdoc, mesothelioma lawyer at Baron and Budd. "Patients and caregivers need to be aware of these newer developments and we are proud to assist in the awareness process." Currently, mesothelioma doctors typically use a multi-modal approach of surgery, radiation and chemotherapy treatment. The combination of treatments is quite aggressive, and can lead to adverse side affects such as nausea, vomiting, and weight loss. Researchers recently … Read more »

Reading Time: 3 minutesMALVERN, Pa., Dec. 7, 2012 /PRNewswire/ --Auxilium Pharmaceuticals, Inc. (AUXL) today announced that executive management will participate in the Oppenheimer Annual Growth Conference to be held December 12-13, 2012 at the Waldorf Astoria Hotel in New York City. Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 2:10 p.m. ET on Thursday, December 13, 2012. (Photo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO) The presentation will also be webcast on the "For Investors" section of the Auxilium website under the "Events" tab on December 13, 2012. The presentation slides to be used will … Read more »